Monte Rosa Therapeutics, Inc.
GLUENASDAQ
Healthcare
Biotechnology
$17.60
+0.51(3.0%)
52W $3.70 – $25.31
Quick:
SCHEDULE 13D/A
Mar 19, 2026 (2 weeks ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
10-K
Mar 17, 2026 (2 weeks ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Feb 17, 2026 (1 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Feb 10, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Jan 21, 2026 (2 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jan 9, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Jan 9, 2026 (2 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Jan 7, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 7, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 16, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Nov 14, 2025 (4 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13D/A
Nov 12, 2025 (4 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
10-Q
Nov 6, 2025 (5 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 6, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Oct 31, 2025 (5 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G
Oct 17, 2025 (5 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G
Oct 3, 2025 (6 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Sep 15, 2025 (6 months ago)Current Report
Material event disclosure
Event materiality and market reaction